20 Mar 2026Open access
Subtherapeutic exposure in doxorubicin pharmacokinetics among Ugandan breast cancer patients: a pilot study with implications for personalized therapyPublisher siteBMC Research Notes, Breast Cancer Treatment Studies
Active, last published 2026
Allan
Buzibye
Scholar“Research profile drawn from open scholarly records.”
Makerere University
Uganda
Claim Your ProfileUganda1
H-index
4
Citations
Allan has not officially claimed their profile. If you are Allan, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Allan Buzibye will appear here once their profile is updated.
02 · Reach
Publication output and reach
Allan's work has been cited 4 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchInfectious Diseases Institute, UgandaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
5 works27 Feb 2026Open access
Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance – A pharmacokinetic assessmentPublisher siteNew Microbes and New Infections, Tuberculosis Research and Epidemiology
2 Feb 2026
Letter to the editor: Mitochondrial DNA patterns among individuals living with HIV-1 on dolutegravir with hyperglycemiaPublisher siteJAIDS Journal of Acquired Immune Deficiency Syndromes, HIV-related health complications and treatments
2 Oct 2024Open access3cites
Interim analysis, a tool to enhance efficiency of pharmacokinetic studies: Pharmacokinetics of rifampicin in lactating mother–infant pairsPublisher siteCPT Pharmacometrics & Systems Pharmacology, Pharmaceutical studies and practices
29 Jul 2024Open access1cites
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeksPublisher siteBMC Infectious Diseases, HIV-related health complications and treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Allan?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you